# Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty

> **NCT06534697** · NA · NOT_YET_RECRUITING · sponsor: **Foisor Orthopedics Clinical Hospital** · enrollment: 210 (estimated)

## Conditions studied

- Hip Osteoarthritis

## Interventions

- **DRUG:** Naropin, 0.2% Injectable Solution in Sodium chloride
- **DRUG:** Naropin, 0.2% Injectable Solution in dextrose 5%
- **DRUG:** Dextrose 10 % in Water

## Key facts

- **NCT ID:** NCT06534697
- **Lead sponsor:** Foisor Orthopedics Clinical Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-22
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-02-28
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06534697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06534697, "Fascia Iliaca Block for Postoperative Pain Control After Elective Hip Arthroplasty". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06534697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*